LP-002(Lepu biopharma)

N/A

Report date: 2024/08/02 15:30:37

Base Information

Drug NameLP-002(Lepu biopharma)

Drug Alias NameLP-002(Lepu biopharma)LP002(Lepu biopharma)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulantsAnti-Programmed death-ligand 1

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLepu Biopharma Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesLepu Biopharma Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A